[OncoHost in PR Newswire] OncoHost publishes landmark study in JPBA demonstrating serum-plasma proteomic bridging, expanding biomarker research capabilities

BINYAMINA, Israel and CARY, N.C., Feb. 18, 2026 /PRNewswire/ — OncoHost, a technology company transforming precision oncology through proteomics and AI, today announced the publication of a new study in the Journal of Pharmaceutical and Biomedical Analysis (JPBA), titled “Bridging the Gap: A Systematic Approach to Integrating Serum and Plasma Proteomic Datasets for Biomarker Studies.”